Novartis Investigative Site

Navi Mumbai, Maharashtra 410210

0 studies enrolling now · 3 studies all time

What they study most

Chronic Spontaneous Urticaria, Graft-versus-host Disease (GVHD), Hidradenitis Suppurativa

Studies at this site

• A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3) — Completed
• Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS) — Completed
• A Phase III Study of Safety and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines — Completed